Cite
APA Citation
Kutschera, M., Primas, C., Reinisch, S., Novacek, G., Kim, S. H., Lee, S. H., Lee, J. H., Reinisch, W., & Mould, D. R. (n.d.). dOP74 Initial Clearance of infliximab is a predictor for the time of formation of anti-drug antibodies. Journal of Crohn's and colitis, 15, S108–S109. http://access.bl.uk/ark:/81055/vdc_100130765682.0x00000b